Teijin Pharma Overview

  • Founded

  • 2002

Founded
  • Status

  • Private

  • Employees

  • 20,000

Employees
  • Investments

  • 6

Teijin Pharma General Information

Description

Manufacturer of pharmaceutical and home healthcare products created to prevent bone and joint, respiratory, and cardiovascular and metabolic diseases. The company provides pharmaceutical drugs, sonic accelerated fracture healing system, oxygen concentrator and airway pressure device, enabling patients to have an improved quality of life through antihyperuricemic treatments.

Contact Information

Website
www.teijin-pharma.com
Ownership Status
Privately Held (backing)
Financing Status
Corporate Backed or Acquired
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Primary Office
  • Kasumigaseki Common Gate West Tower, 2-1
  • Kasumigaseki 3-chome, Chiyoda-ku
  • Tokyo, 100-8585
  • Japan

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Teijin Pharma Patents

  • 1,065

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 83

    Granted

  • 15

    Pending

  • 000

    Expiring in next 12 mo

Teijin Pharma Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
JP-2021069862-A Respiratory gas supply device and control method of the same Pending 01-Nov-2019 0000000000
DE-102020211202-A1 Gas supply device for breathing and control procedures for it Pending 01-Nov-2019 0000000000
JP-2022526609-A Benzimidazole derivatives and their use Pending 11-Apr-2019 0000000000
CA-3136351-A1 Benzimidazole derivatives and their uses Pending 11-Apr-2019 0000000000
US-20220008685-A1 Breathing apparatus Pending 14-Dec-2018 A61M16/201
To view Teijin Pharma’s complete patent history, request access »

Teijin Pharma Executive Team (1)

Name Title Board Seat Contact Info
Taiichi Machida General Manager
To view Teijin Pharma’s complete executive team members history, request access »

Teijin Pharma Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Teijin Pharma Investments & Acquisitions (6)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000 31-May-2021 00000 0000 00000 Other Healthcare Services
000000 000000 01-Apr-2021 000000000 00.000 Buildings and Property
000000 000000 05-Jun-2014 000000000 Pharmaceuticals
000000 000000 02-Apr-2013 000000000 Pharmaceuticals
Esteve Teijin España 08-Jan-2009 Merger/Acquisition Industrial Chemicals
You’re viewing 5 of 6 investments and acquisitions. Get the full list »